The Biocompatibles’ Drug-Eluting Stents
- 22 November 2001
- book chapter
- Published by Taylor & Francis
- p. 313-324
- https://doi.org/10.1201/b16798-39
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Paclitaxel and Cell DivisionNew England Journal of Medicine, 2001
- Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary ArteriesCirculation, 2001
- Coronary in-stent restenosis—predictors, treatment and preventionEuropean Heart Journal, 2000
- Stent coatings and local drug delivery. State of the artPublished by Oxford University Press (OUP) ,1999
- Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.The American Journal of Cardiology, 1998
- Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug DeliveryCirculation, 1997
- Epithelial ovarian carcinomaThe Lancet, 1997
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.Journal of Clinical Investigation, 1995
- Promotion of microtubule assembly in vitro by taxolNature, 1979